Many factors contribute to mortality in lung cancer, including the presence of concomitant
cardiovascular disease. In the treatment of early stage of lung cancer, the presence of …

Background and aims There is limited data on temporal trends of cardiovascular
hospitalizations and outcomes amongst cancer patients. We describe the distribution, trends …

Simple Summary Cardiovascular disease and cancer are the leading causes of
hospitalization and mortality in high-income countries. Studies of myocardial infarction show …

Abstract Background Human apolipoprotein E (APOE) polymorphisms are attributable to the
presence of three common alleles, namely, ε2, ε3, and ε4, which generate six genotypes, viz …

Introduction: Several lines of evidence reveal that cardiovascular disease (CVD) and cancer
share similar common pathological milieus. The prevalence of the two diseases is growing …

Aims Limited evidence exists regarding the outcomes of cancer patients hospitalized with
new onset acute heart failure (AHF). We assessed the in‐hospital mortality and 1 year …

Objective. The cardiac safety of concurrent treatment with anthracycline (A),
cyclophosphamide (C), and paclitaxel (T) in an adjuvant BC treatment regimen is still under …

Background: The complex clinical status of heart failure (HF) patients with concomitant
cancer is gaining clinical interest. This study sought to explore the prevalence of cancer in …

Objective To assess the effects of Hong Huang Decoction (HHD), a Chinese herbal
medicine, on myocardial injury in breast cancer patients who underwent anthracycline (ANT) …

Background There is conflicting evidence regarding whether heart failure (HF) increases the
risk of develo** cancer. Objective This study aimed to assess the association between HF …